Now Playing

Eyewire TV September 14, 2022 thumbnail

Introduction

story 1 thumbnail

Trials Examine Use of High-Dose Aflibercept for 12- and 16-Week Dosing for Wet AMD and DME

story 2 thumbnail

Trukera Medical Launches the ScoutPro Osmolarity System in the US

story 3 thumbnail

Tarsus Submits NDA to the FDA for Demodex Blepharitis Drug Candidate


Previous EyewireTV Episodes